Gary Ingenito, Chief Medical & Reg. Officer at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 143,000 shares at $15.65 ($2.2M) on 2022-09-14, disclosed to the SEC on 2022-09-16.
Open-market sale of $2.2M CPRX by Chief Medical & Reg. Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.65 | 55,000 | $861K | 38.4% |
| 2 | $15.69 | 88,000 | $1.4M | 61.6% |
| Total | $15.67 avg | 143,000 | $2.2M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-29 | $545K | — | Filing → |
| CPRX | SELL | 2024-11-22 | $806K | — | Filing → |
| CPRX | SELL | 2024-08-13 | $1.8M | — | Filing → |